[go: up one dir, main page]

WO2003043610A3 - A process for manufacture of a sustained release composition containing microbe - Google Patents

A process for manufacture of a sustained release composition containing microbe Download PDF

Info

Publication number
WO2003043610A3
WO2003043610A3 PCT/IN2002/000223 IN0200223W WO03043610A3 WO 2003043610 A3 WO2003043610 A3 WO 2003043610A3 IN 0200223 W IN0200223 W IN 0200223W WO 03043610 A3 WO03043610 A3 WO 03043610A3
Authority
WO
WIPO (PCT)
Prior art keywords
manufacture
composition containing
sustained release
release composition
containing microbe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2002/000223
Other languages
French (fr)
Other versions
WO2003043610A2 (en
Inventor
Amit Krishna Antarkar
Rajendra Ghanshamlal Lala
Gaurang Hasmukhlal Thanawala
Maya Janak Shah
Janak Ramanlal Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Themis Laboratories Pvt Ltd
Original Assignee
Themis Laboratories Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Themis Laboratories Pvt Ltd filed Critical Themis Laboratories Pvt Ltd
Priority to AU2002356425A priority Critical patent/AU2002356425A1/en
Priority to HU0500382A priority patent/HUP0500382A3/en
Priority to EP02803493A priority patent/EP1448173A2/en
Publication of WO2003043610A2 publication Critical patent/WO2003043610A2/en
Publication of WO2003043610A3 publication Critical patent/WO2003043610A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel compositions and process for manufacturing of novel pharmaceutical compositions in the form of microbeads comprising of trimetazidine dihydrochloride and further coating of the beads with polymeric membrane to tailor the drug release characteristics enabling 'once a day' dosing for 60 mg dose of trimetazidine dihydrochloride per unit dose.
PCT/IN2002/000223 2001-11-21 2002-11-20 A process for manufacture of a sustained release composition containing microbe Ceased WO2003043610A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002356425A AU2002356425A1 (en) 2001-11-21 2002-11-20 A process for manufacture of a sustained release composition containing microbe
HU0500382A HUP0500382A3 (en) 2001-11-21 2002-11-20 Sustained release pharmaceutical compositions containing microbeads of trimetazidine dihydrochloride and process for producing them
EP02803493A EP1448173A2 (en) 2001-11-21 2002-11-20 A process for manufacture of a sustained release pharmaceutical composition containing microbeads of trimetazidine dihydrochloride

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1106MU2001 2001-11-21
IN1106/MUM/2001 2001-11-21

Publications (2)

Publication Number Publication Date
WO2003043610A2 WO2003043610A2 (en) 2003-05-30
WO2003043610A3 true WO2003043610A3 (en) 2003-08-21

Family

ID=11097321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2002/000223 Ceased WO2003043610A2 (en) 2001-11-21 2002-11-20 A process for manufacture of a sustained release composition containing microbe

Country Status (4)

Country Link
EP (1) EP1448173A2 (en)
AU (1) AU2002356425A1 (en)
HU (1) HUP0500382A3 (en)
WO (1) WO2003043610A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885807B1 (en) * 2005-05-18 2008-05-16 Mg Pharma SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD
EP2200591A2 (en) 2007-09-11 2010-06-30 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine
TR201001902A2 (en) 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Trimetazidine tablets with extended release
US20110274751A1 (en) 2010-05-04 2011-11-10 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Trimetazidine formulation with different release profiles
CN102133195A (en) * 2011-03-17 2011-07-27 王国栋 Trimetazidine dihydrochloride sustained control release pellet and preparation method thereof
FR2986431B1 (en) * 2012-02-03 2017-03-17 Servier Lab PROLONGED RELEASE OF TRIMETAZIDINE PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PRODUCTION THEREOF AND USE IN THERAPEUTIC TREATMENTS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0673649A1 (en) * 1994-03-24 1995-09-27 Adir Et Compagnie Pharmaceutical compositions for the prolonged release of trimetazidine after oral administration

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0673649A1 (en) * 1994-03-24 1995-09-27 Adir Et Compagnie Pharmaceutical compositions for the prolonged release of trimetazidine after oral administration

Also Published As

Publication number Publication date
HUP0500382A3 (en) 2008-03-28
WO2003043610A2 (en) 2003-05-30
AU2002356425A8 (en) 2003-06-10
HUP0500382A2 (en) 2005-07-28
EP1448173A2 (en) 2004-08-25
AU2002356425A1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
CA2253980A1 (en) Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
DE60321386D1 (en) PHARMACEUTICAL PREPARATION FOR MODIFIED RELEASE
GB0003154D0 (en) Novel compounds
WO2007052125A3 (en) Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent
IL220888A0 (en) 3,10 and 12 a substituted tetracyline compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
CA2375946A1 (en) Pharmaceutical tablet and process for making thereof
HUP0203451A2 (en) Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
IL167038A (en) Pyrazole derivatives, pharmaceutical compositions containing the same, use thereof in the manufacture of medicaments and intermediate for production thereof
WO2004012699A3 (en) Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
WO2005048979A3 (en) Pharmaceutical composition having casing with multiple micro tablets
RU2002102701A (en) Stable oral hydrogel-forming, pharmaceutical composition, method for its preparation, method for preventing changes in drug release, method for increasing physical stability of the oral composition
IL204947A0 (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use in the manufacture of medicaments, pharmaceutical compositions and kits comprising them
ATE321537T1 (en) PHARMACEUTICAL PREPARATION CONTAINING DOXAZOSINE
AU2003215245A1 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
SI1417206T1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
CA2445519A1 (en) Method for manufacturing a low dose pharmaceutical composition
CA2489407A1 (en) Lasofoxifene tablet and its coating
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
ATE442852T1 (en) DELAYED-RELEASE MEDICINAL COMPRISING TRIMETAZIDINE AND METHOD FOR THE PRODUCTION
WO2003043610A3 (en) A process for manufacture of a sustained release composition containing microbe
PL379465A1 (en) Sutained release formulation for venlafaxine hydrochloride
AU2002348829A1 (en) Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
WO2003048298A3 (en) Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
IL162385A (en) Benzothiazole - and benzoxazole - 4,7 - dione derivatives, uses thereof for the preparation of a medicament, medicaments containing them and pharmaceutical compositions containing them
BE2016C017I2 (en)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002803493

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002803493

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP